Indian equity benchmark indices failed to hold on to their intraday gains and ended with little change on June 10 amid broad-based selling pressure across sectors, except FMCG and private banks.


Tracking weak global cues, amid escalating geopolitical tensions, the market opened on a subdued note but gradually gained momentum during the session, with the Nifty briefly crossing the 23,400 mark intraday. However, profit-booking in the final hour of trade wiped out most of the gains, dragging  the benchmarks close to their day's lows.

At close, the Sensex was up 64.42 points or 0.09 percent at 73,983.18, and the Nifty was down 27.15 points or 0.12 percent at 23,214.95.

The Indian rupee surrendered a major portion of its intraday gains but managed to end the session higher, appreciating 8 paise to close at 95.27 per dollar on Wednesday, compared with its previous close of 95.35.

Broader markets underperformed, with the Nifty Midcap and Nifty Smallcap indices declining around 1.5% and 1.3%, respectively.

On the Nifty, Nestle India, Axis Bank, Kotak Mahindra Bank, Hindustan Unilever, and ICICI Bank emerged as the top gainers, while Coal India, Hindalco Industries, Infosys, ONGC, and Eternal were among the key losers.

Sectorally, FMCG and private banking stocks outperformed, whereas all other major indices ended in the red, with media, realty, energy, metal, oil & gas, , and PSU bank indices falling 1-2%.

More than 100 stocks touched their 52-week high on the BSE, including Caplin Labs, Cemindia Projects, Chennai Petro, Aster DM Health, Apollo Hospitals, Zydus Life, Sai Life Science, RBL Bank, Federal Bank, JK Bank, Syrma SGS, Data Patterns, among others.

Among individual stocks, Hinduja Global Solutions surged 11% after launching Project GANGA, while Afcons Infrastructure rallied 4% after securing a ?5,301-crore breakwater project for Vadhvan Port. Clean Max Enviro Energy gained 10% following a 900 MW renewable energy partnership with Meta Platforms.

Concord Biotech advanced 4% after receiving USFDA approval for Tofacitinib tablets, while HDFC Bank added 1% after the Bombay High Court dismissed an interim application filed by the Lilavati Kirtilal Mehta Medical Trust.

On the downside, Welspun Corp slipped 3.2% after its subsidiary divested a 4.5% stake in Saudi Arabia-based East Pipes Integrated Company for Industry (EPIC).